APA (7th ed.) Citation

Gameiro, A., Almeida, F., Nascimento, C., Correia, J. M. d. J., & Ferreira, F. (2022). Tyrosine kinase inhibitors are promising therapeutic tools for cats with HER2-positive mammary carcinoma.

Chicago Style (17th ed.) Citation

Gameiro, Andreia, Filipe Almeida, Catarina Nascimento, Jorge Manuel de Jesus Correia, and Fernando Ferreira. Tyrosine Kinase Inhibitors Are Promising Therapeutic Tools for Cats with HER2-positive Mammary Carcinoma. 2022.

MLA (8th ed.) Citation

Gameiro, Andreia, et al. Tyrosine Kinase Inhibitors Are Promising Therapeutic Tools for Cats with HER2-positive Mammary Carcinoma. 2022.